BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31679897)

  • 1. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Pham HP; Schwartz J
    Presse Med; 2019 Nov; 48(11 Pt 2):338-346. PubMed ID: 31679897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Lindenbaum Y; Kissel JT; Mendell JR
    Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
    Querol L; Lleixà C
    Neurotherapeutics; 2021 Oct; 18(4):2222-2235. PubMed ID: 34549385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C; Grecò M; Polo A; Del Colle R
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated (Centrifugal) therapeutic plasma exchange option for guillain-barre syndrome: A report from Calabar, Nigeria.
    Iheanacho OE; Chimeziem C; Sachais BS; Shi PA
    Niger J Clin Pract; 2017 Oct; 20(10):1350-1354. PubMed ID: 29192644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
    Kanbayashi T; Sonoo M
    Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K; Hattori N; Sobue G
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurologic indications for therapeutic plasma exchange: 2011 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2012; 27(3):138-45. PubMed ID: 22522566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of immune neuropathies.
    Van Doorn PA; Garssen MP
    Curr Opin Neurol; 2002 Oct; 15(5):623-31. PubMed ID: 12352007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of immune-mediated inflammatory neuropathies.
    Hadden RD; Hughes RA
    Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchanges. A still effective treatment.
    Guillevin L
    Presse Med; 2019 Nov; 48(11 Pt 2):317-318. PubMed ID: 31806125
    [No Abstract]   [Full Text] [Related]  

  • 20. Deterioration after Guillain-Barré syndrome: recurrence, treatment-related fluctuation or CIDP?
    Hadden RD
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):3. PubMed ID: 19091702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.